These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30880267)

  • 1. Seasonality and community interventions in a mathematical model of Clostridium difficile transmission.
    McLure A; Furuya-Kanamori L; Clements ACA; Kirk M; Glass K
    J Hosp Infect; 2019 Jun; 102(2):157-164. PubMed ID: 30880267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.
    van Kleef E; Deeny SR; Jit M; Cookson B; Goldenberg SD; Edmunds WJ; Robotham JV
    Vaccine; 2016 Nov; 34(46):5562-5570. PubMed ID: 27727031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003-2011.
    Marufu O; Desai N; Aldred D; Brown T; Eltringham I
    J Hosp Infect; 2015 Jan; 89(1):38-45. PubMed ID: 25480022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.
    Stephenson B; Lanzas C; Lenhart S; Ponce E; Bintz J; Dubberke ER; Day J
    BMC Infect Dis; 2020 Oct; 20(1):799. PubMed ID: 33115427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
    Price J; Cheek E; Lippett S; Cubbon M; Gerding DN; Sambol SP; Citron DM; Llewelyn M
    Clin Microbiol Infect; 2010 Aug; 16(8):1297-302. PubMed ID: 19832710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare-Associated Clostridium difficile Infections are Sustained by Disease from the Community.
    McLure A; Clements ACA; Kirk M; Glass K
    Bull Math Biol; 2017 Oct; 79(10):2242-2257. PubMed ID: 28776206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia.
    Chalmers JD; Akram AR; Singanayagam A; Wilcox MH; Hill AT
    J Infect; 2016 Jul; 73(1):45-53. PubMed ID: 27105657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity.
    Forster AJ; Daneman N; van Walraven C
    J Hosp Infect; 2017 Apr; 95(4):400-409. PubMed ID: 27825674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings.
    Maghdoori S; Moghadas SM
    BMC Infect Dis; 2017 Jun; 17(1):384. PubMed ID: 28577357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.
    Barker AK; Alagoz O; Safdar N
    Clin Infect Dis; 2018 Apr; 66(8):1192-1203. PubMed ID: 29112710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.
    Grigoras CA; Zervou FN; Zacharioudakis IM; Siettos CI; Mylonakis E
    PLoS One; 2016; 11(6):e0156577. PubMed ID: 27258068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series.
    Fowler S; Webber A; Cooper BS; Phimister A; Price K; Carter Y; Kibbler CC; Simpson AJ; Stone SP
    J Antimicrob Chemother; 2007 May; 59(5):990-5. PubMed ID: 17387117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antibiotics and the prevalence of antibiotic-associated diarrhoea in patients with spinal cord injuries: an international, multi-centre study.
    Wong S; Santullo P; Hirani SP; Kumar N; Chowdhury JR; García-Forcada A; Recio M; Paz F; Zobina I; Kolli S; Kiekens C; Draulans N; Roels E; Martens-Bijlsma J; O'Driscoll J; Jamous A; Saif M
    J Hosp Infect; 2017 Oct; 97(2):146-152. PubMed ID: 28647425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
    Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
    JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
    DiDiodato G; McArthur L
    PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network.
    Rhea S; Jones K; Endres-Dighe S; Munoz B; Weber DJ; Hilscher R; MacFarquhar J; Sickbert-Bennett E; DiBiase L; Marx A; Rineer J; Lewis J; Bobashev G;
    PLoS One; 2020; 15(6):e0234031. PubMed ID: 32525887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.
    Nissle K; Kopf D; Rösler A
    BMC Geriatr; 2016 Nov; 16(1):185. PubMed ID: 27846818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers.
    McLure A; Clements ACA; Kirk M; Glass K
    Epidemiol Infect; 2019 Jan; 147():e152. PubMed ID: 31063089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
    Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.